
Utah Medical Products UTMD
$ 74.23
-1.07%
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
3.24 M |
Market Cap[1] |
$ 241 M |
EBITDA (LTM) |
$ 12.2 M |
P/E (LTM) |
20.431034 |
P/S (LTM) |
5.617675 |
EPS (LTM) |
3.48 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
$ 38.61 | 3.51 % | $ 1.84 B | Nasdaq Global Select Market | ||
|
electroCore
ECOR
|
$ 7.05 | -4.86 % | $ 59.8 K | Nasdaq Global Select Market | ||
|
Alcon
ALC
|
$ 70.17 | -0.69 % | $ 34.6 B | NYSE | ||
|
Glaukos Corporation
GKOS
|
$ 178.88 | 1.14 % | $ 10.2 B | NYSE,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 13.94 | -1.13 % | $ 288 M | NYSE American | ||
|
iRhythm Technologies
IRTC
|
$ 121.27 | 1.36 % | $ 3.88 B | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 452.29 | 1.9 % | $ 161 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 3.17 | 3.09 % | $ 146 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 84.45 | -1.03 % | $ 1.91 B | Nasdaq Global Market,SPB | ||
|
AtriCure
ATRC
|
$ 58.97 | -0.56 % | $ 2.82 B | Nasdaq Global Market,SPB | ||
|
Milestone Scientific
MLSS
|
$ 0.31 | -2.09 % | $ 25.4 M | NYSE American | ||
|
Nephros
NEPH
|
$ 3.53 | 0.28 % | $ 37.5 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 198.91 | -0.75 % | $ 57.2 B | NYSE,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 23.6 | -1.54 % | $ 3.96 B | NYSE | ||
|
Pro-Dex
PDEX
|
$ 62.22 | -0.26 % | $ 201 B | Nasdaq Global Select Market | ||
|
Repligen Corporation
RGEN
|
$ 176.93 | -1.0 % | $ 9.95 M | Nasdaq Global Select Market,SPB | ||
|
ResMed
RMD
|
$ 252.86 | -0.08 % | $ 36.8 B | NYSE,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 22.61 | 0.53 % | $ 1.12 B | Nasdaq Global Market,SPB | ||
|
STERIS plc
STE
|
$ 232.15 | -0.03 % | $ 22.8 B | NYSE,SPB | ||
|
Stereotaxis
STXS
|
$ 1.02 | 2.2 % | $ 92.8 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 136.29 | -0.43 % | $ 6.08 B | NYSE,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 392.15 | -0.47 % | $ 28.4 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 9.43 | -0.74 % | $ 1.88 B | Nasdaq Global Select Market,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
AngioDynamics
ANGO
|
$ 12.37 | 2.87 % | $ 514 M | Nasdaq Global Select Market | ||
|
Baxter International
BAX
|
$ 25.3 | -1.38 % | $ 13 B | NYSE,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 118.51 | 2.0 % | $ 5.59 B | NYSE,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 8.23 | -1.32 % | $ 365 M | Nasdaq Global Market | ||
|
ICU Medical
ICUI
|
$ 166.62 | -1.02 % | $ 4.11 B | Nasdaq Global Select Market,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 93.3 | -0.68 % | $ 5.52 B | Nasdaq Global Select Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 53.02 | 0.65 % | $ 3.57 B | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 4.13 | 8.68 % | $ 303 M | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.58 | -0.33 % | $ 17.4 M | NYSE American | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
The Cooper Companies
COO
|
$ 61.21 | -0.71 % | $ 12.2 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 0.97 | 3.4 % | $ 44.4 M | Nasdaq Global Select Market | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.